These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
223 related items for PubMed ID: 17428367
1. Current knowledge on cellular interactions in the WG-granuloma. Lamprecht P, Gross WL. Clin Exp Rheumatol; 2007; 25(1 Suppl 44):S49-51. PubMed ID: 17428367 [Abstract] [Full Text] [Related]
2. Proteinase 3, protease-activated receptor-2 and interleukin-32: linking innate and autoimmunity in Wegener's granulomatosis. Csernok E, Holle JU, Gross WL. Clin Exp Rheumatol; 2008; 26(3 Suppl 49):S112-7. PubMed ID: 18799068 [Abstract] [Full Text] [Related]
3. Is PR3-ANCA formation initiated in Wegener's granulomatosis lesions? Granulomas as potential lymphoid tissue maintaining autoantibody production. Voswinkel J, Müller A, Lamprecht P. Ann N Y Acad Sci; 2005 Jun; 1051():12-9. PubMed ID: 16126940 [Abstract] [Full Text] [Related]
4. [B lymphocyte differentiation in granulomatous tissues of the lung and the nasal mucosa in Wegener's granulomatosis: origin of anti-neutrophil cytoplasmic antibody formation?]. Krämer JA, Müller A, Herlyn K, Pitann S, Lamprecht P, Holl-Ulrich K, Feller AC, Gross WL, Gause A, Voswinkel J. Z Rheumatol; 2007 Sep; 66(5):421-9. PubMed ID: 17516076 [Abstract] [Full Text] [Related]
5. Leucocyte membrane expression of proteinase 3 correlates with disease activity in patients with Wegener's granulomatosis. Muller Kobold AC, Kallenberg CG, Tervaert JW. Br J Rheumatol; 1998 Aug; 37(8):901-7. PubMed ID: 9734683 [Abstract] [Full Text] [Related]
6. Pathogenesis of Wegener's granulomatosis. Gross WL, Trabandt A, Csernok E. Ann Med Interne (Paris); 1998 Sep; 149(5):280-6. PubMed ID: 9791561 [Abstract] [Full Text] [Related]
7. A novel system to test for specificity of B cell receptors from tissue of Wegener's granulomatosis patients. Voswinkel J, Kerkdijk AJ, Mueller A, Assmann G, Pfreundschuh M, Held G. Clin Exp Rheumatol; 2008 Sep; 26(3 Suppl 49):S90-6. PubMed ID: 18799062 [Abstract] [Full Text] [Related]
8. T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG). Brouwer E, Stegeman CA, Huitema MG, Limburg PC, Kallenberg CG. Clin Exp Immunol; 1994 Dec; 98(3):448-53. PubMed ID: 7994909 [Abstract] [Full Text] [Related]
9. Distinct proteinase 3-induced cytokine patterns in Wegener´s granulomatosis, Churg-Strauss syndrome, and healthy controls. Fagin U, Csernok E, Müller A, Pitann S, Fazio J, Krause K, Bremer P, Wipfler-Freissmuth E, Moosig F, Gross WL, Lamprecht P. Clin Exp Rheumatol; 2011 Dec; 29(1 Suppl 64):S57-62. PubMed ID: 21470489 [Abstract] [Full Text] [Related]
11. Current understanding of the pathogenesis of granulomatosis with polyangiitis (Wegener's). Csernok E, Gross WL. Expert Rev Clin Immunol; 2013 Jul; 9(7):641-8. PubMed ID: 23899234 [Abstract] [Full Text] [Related]
12. Inhibition of proteinase 3 by ANCA and its correlation with disease activity in Wegener's granulomatosis. Daouk GH, Palsson R, Arnaout MA. Kidney Int; 1995 Jun; 47(6):1528-36. PubMed ID: 7643521 [Abstract] [Full Text] [Related]
13. Expansion of circulating NKG2D+ effector memory T-cells and expression of NKG2D-ligand MIC in granulomaous lesions in Wegener's granulomatosis. Capraru D, Müller A, Csernok E, Gross WL, Holl-Ulrich K, Northfield J, Klenerman P, Herlyn K, Holle J, Gottschlich S, Voswinkel J, Spies T, Fagin U, Jabs WJ, Lamprecht P. Clin Immunol; 2008 May; 127(2):144-50. PubMed ID: 18313361 [Abstract] [Full Text] [Related]
14. Antibodies to proteinase 3 prime human oral, lung, and kidney epithelial cells to secrete proinflammatory cytokines upon stimulation with agonists to various Toll-like receptors, NOD1, and NOD2. Uehara A, Hirabayashi Y, Takada H. Clin Vaccine Immunol; 2008 Jul; 15(7):1060-6. PubMed ID: 18495849 [Abstract] [Full Text] [Related]
15. B lymphocyte maturation in Wegener's granulomatosis: a comparative analysis of VH genes from endonasal lesions. Voswinkel J, Mueller A, Kraemer JA, Lamprecht P, Herlyn K, Holl-Ulrich K, Feller AC, Pitann S, Gause A, Gross WL. Ann Rheum Dis; 2006 Jul; 65(7):859-64. PubMed ID: 16291812 [Abstract] [Full Text] [Related]
16. Antineutrophil cytoplasmic antibodies to proteinase 3 in Wegener's granulomatosis: epitope analysis using synthetic peptides. Van Der Geld YM, Simpelaar A, Van Der Zee R, Tervaert JW, Stegeman CA, Limburg PC, Kallenberg CG. Kidney Int; 2001 Jan; 59(1):147-59. PubMed ID: 11135067 [Abstract] [Full Text] [Related]
17. Cutaneous manifestations of Wegener's granulomatosis: a clinicopathologic study of 17 patients and correlation to antineutrophil cytoplasmic antibody status. Comfere NI, Macaron NC, Gibson LE. J Cutan Pathol; 2007 Oct; 34(10):739-47. PubMed ID: 17880578 [Abstract] [Full Text] [Related]
18. Human anti-neutrophil cytoplasm autoantibodies to proteinase 3 (PR3-ANCA) bind to neutrophils. Van Rossum AP, van der Geld YM, Limburg PC, Kallenberg CG. Kidney Int; 2005 Aug; 68(2):537-41. PubMed ID: 16014030 [Abstract] [Full Text] [Related]
19. Wegener autoantigen induces maturation of dendritic cells and licenses them for Th1 priming via the protease-activated receptor-2 pathway. Csernok E, Ai M, Gross WL, Wicklein D, Petersen A, Lindner B, Lamprecht P, Holle JU, Hellmich B. Blood; 2006 Jun 01; 107(11):4440-8. PubMed ID: 16478888 [Abstract] [Full Text] [Related]
20. Glycosylation of proteinase 3 (PR3) is not required for its reactivity with antineutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis. Finkielman JD, Merkel PA, Schroeder D, Hoffman GS, Spiera R, St Clair EW, Davis JC, McCune WJ, Lears A, Ytterberg SR, Hummel AM, Viss MA, Peikert T, Stone JH, Specks U, WGET Research Group. Clin Exp Rheumatol; 2009 Jun 01; 27(1 Suppl 52):S45-52. PubMed ID: 19646346 [Abstract] [Full Text] [Related] Page: [Next] [New Search]